TCL6 and breast cancer: Also, lncRNAs like GATA3-AS1, LINC00624, TCL6, LINC00426, and MIAT have BC subtype-specific expression that can be useful for proper designing and specific implementation for patients’ stratification strategies and immunotherapies based on lncRNAs in BC in the next coming years.